Year: 2013
Type: review
Abstract: Ultrasound is an important local stimulus for triggering drug release at the target tissue. Ultrasound-responsive drug delivery systems (URDDS) have become an important research focus in targeted therapy. URDDS include many different formulations, such as microbubbles, nanobubbles, nanodroplets, liposomes, emulsions, and micelles. Drugs that can be loaded into URDDS include small molecules, biomacromolecules, and inorganic substances. Fields of clinical application include anticancer therapy, treatment of ischemic myocardium, induction of an immune response, cartilage tissue engineering, transdermal drug delivery, treatment of Huntington's disease, thrombolysis, and disruption of the blood-brain barrier. This review focuses on recent advances in URDDS, and discusses their formulations, clinical application, and problems, as well as a perspective on their potential use in the future.
DOI: 10.2147/ijn.s43589
Language: English
Subfield: Biomedical Engineering
Field: Engineering
Domain: Physical Sciences
Keywords: ultrasound-responsive drug delivery, ultrasound-triggered drug release, microbubbles, nanobubbles, nanodroplets, liposomes, emulsions, micelles, targeted drug delivery, cancer therapy, ischemic myocardium, immune response, cartilage tissue engineering, transdermal drug delivery, Huntington's disease, thrombolysis, blood-brain barrier disruption
Open Access status: gold
Estimated APC paid: $2,836
OpenAlex ID: W1973524221
